On March 5, 71-year-old resident of Riga, Oleg Zeigermacher, received the first dose of AstraZeneca of the ABV5300 batch, the use of which was suspended in early March by several EU countries, including Latvia.
After that, he developed symptoms of a mild cold, and on March 9 he died of pulmonary edema as a result of bilateral pneumonia.
“In principle, this is the question - on the one hand, both the doctor from the intensive care unit and the ambulance doctor named us a thing related to blood clots.
We read in the newspapers that in Austria, in Germany, AstraZeneca causes blood clots, ”Delfi quoted Pavel Zeigermacher, the son of the deceased, as saying.
It is noted that Oleg Zeigermacher was vaccinated with AstraZeneca batch ABV5300.
The use of this particular series was suspended in early March by several EU countries.
Serious complications following this series of vaccinations were reported by Austria.
On March 31, the European Medicines Agency (EMA) announced that a possible link between coronavirus vaccination with a drug developed by AstraZeneca and the formation of blood clots has not been proven at the moment, but it is possible.
German Health Minister Jens Spahn called the situation around the AstraZeneca vaccine in Europe a blow.